This article describes the CMS hierarchical condition categories (HCC) model implemented in 2004 to adjust Medicare capitation payments to private health care plans for the health expenditure risk of… (More)
The Diagnostic Cost Group Hierarchical Condition Category (DCG/HCC) payment models summarize the health care problems and predict the future health care costs of populations. These models use the… (More)
The diagnostic cost group approach to a reimbursement model for health maintenance organizations is presented. Diagnostic information about previous hospitalizations is used to create empirically… (More)
The Balanced Budget Act (BBA) of 1997 required HCFA to implement health-status-based risk adjustment for Medicare capitation payments for managed care plans by January 1, 2000. In support of this… (More)
Preface The Centers for Medicare and Medicaid Services (CMS), through a subcontract with Yale New is supporting a committee appointed by the Committee of Presidents of Statistical Societies (COPSS)… (More)
Greater family responsibilities and more child rearing duties have been suggested as possible reasons for lower academic productivity and slower career progress for women compared with men in… (More)
OBJECTIVE
To examine the value of two kinds of patient-level dat a (cost and diagnoses) for identifying a very small subgroup of a general population with high future costs that may be mitigated with… (More)
Academic medicine : journal of the Association of…
1998
PURPOSE
To determine (1) the prevalence of mentoring relationships for U.S. medical school junior faculty; (2) the quality of these mentoring relationships; (3) any variation by gender or race; and… (More)
Context Some worry that physicians prescribe chemotherapy for patients with cancer at the end of life even when treatment is unlikely to prolong life or palliate symptoms. Contribution Among the… (More)
BACKGROUND
Predicting health care costs for individuals and populations is essential for managing care. However, the comparative power of diagnostic and drug data for predicting future costs has not… (More)